Simsen Diagnostics is a Swedish biotech company that focuses on revolutionizing cancer monitoring through personalized and ultrasensitive technologies. Their flagship product, Simsen® Personal, is a customized cancer DNA test designed to provide remarkable sensitivity and specificity from a simple blood sample. This innovative approach recognizes the unique genetic makeup of each tumor, moving away from standardized testing methods that may not adequately detect cancer in individual patients. By tailoring the testing process to the specific DNA mutations present in a patient's tumor, Simsen Diagnostics aims to enhance the accuracy of cancer monitoring and ultimately contribute to making cancer a curable disease.

The company leverages advanced sequencing technologies, particularly in the realm of ultrasensitive monitoring, to track cancer progression and treatment response more effectively. This approach not only improves the detection of cancerous changes at an early stage but also allows for more personalized treatment strategies. With a team of experienced professionals, including experts in bioinformatics and laboratory management, Simsen Diagnostics is committed to ensuring high-quality testing and fostering an optimal environment for research and development in cancer diagnostics. Their mission underscores the importance of personalized medicine in the fight against cancer, aiming to provide patients and their families with more precise and effective monitoring solutions.

Sweden

We develop technologies for ultrasensitive analysis of complex DNA sources. Compared to other technologies for ultrasensitive sequencing, our solutions are both simple to use and specifically adapted for analysis of difficult to analyze DNA such as circulating tumor DNA, a biomarker specific for cancer.

Simsen Diagnostics

Company Details